Cargando…
Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However, the peroral administration of the medicine is greatly affected by its poor bioavailability as a result of its extensive first-pass effe...
Autores principales: | Ahmed, Osama A. A., A. Fahmy, Usama, Badr-Eldin, Shaimaa M., Aldawsari, Hibah M., Awan, Zuhier A., Asfour, Hani Z., Kammoun, Ahmed K., Caruso, Giuseppe, Caraci, Filippo, Alfarsi, Anas, A. Al-Ghamdi, Raniyah, A. Al-Ghamdi, Rawan, Alhakamy, Nabil A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408465/ https://www.ncbi.nlm.nih.gov/pubmed/32610539 http://dx.doi.org/10.3390/nano10071270 |
Ejemplares similares
-
Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin
por: Fahmy, Usama A, et al.
Publicado: (2020) -
Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo/In Vivo Evaluation
por: Fahmy, Usama A., et al.
Publicado: (2020) -
Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment
por: Alharbi, Waleed S., et al.
Publicado: (2022) -
The Encapsulation of Febuxostat into Emulsomes Strongly Enhances the Cytotoxic Potential of the Drug on HCT 116 Colon Cancer Cells
por: Fahmy, Usama A., et al.
Publicado: (2020) -
The Enhanced Cytotoxic and Pro-Apoptotic Effects of Optimized Simvastatin-Loaded Emulsomes on MCF-7 Breast Cancer Cells
por: Awan, Zuhier A., et al.
Publicado: (2020)